@MassBio's MassCONNECT mentorship program links #startups with seasoned life sciences professionals. Follow us for the latest from & for #entrepreneurs.
Technological innovation is expanding the frontier of what is possible within human health.
Join @JLABS as we discuss the latest trends and how best to accelerate digital innovation with the aim to transform patient care. Register before it’s too late! https://t.co/A7MgG97793
Just learned that we have earned a place as a Finalist in the 10th Annual @UMassM2D2 $200K Challenge. We are among the 15 finalists out of the record 173 applications!
Congratulations to all the finalists and see you at the Challenge Pitch-Off showcase end of March!
Very exciting news from @UMassMedical!
The first human clinical trial of Lyme PrEP, a seasonal shot to prevent #LymeDisease, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment. 💉 https://t.co/EZFUA61FwR
When Frederic Vigneault joined the Wyss he was used to the rigidity of industry. Now he enjoys our environment of innovation. He's currently working on 3 therapeutic projects. Learn about Frederic & his work in this Humans of the Wyss: ATT Edition. #HOWyss https://t.co/zaogssfH0H
New Roivant CEO Matt Gline has crafted an all-equity upfront deal to buy out a Boston-based biotech that has been toiling for several years now at building a supercomputing-based computational platform to design new drugs.
https://t.co/GcTrXclbfC
The @broadinstitute, @DanaFarber, and @count_me_in have been awarded a new $16 million grant from @theNCI to accelerate research in two rare forms of cancer.
https://t.co/xUmoC8kYv7
This week, MassBio’s @Mass_CONNECT launched its first mentorship cycle of 2021 with a virtual opening showcase. Read the press release to learn more about the participating startups: https://t.co/tn2PKp9LYZ
Dr. Lindsey R. Baden and a research team across @BrighamWomens Division of Infectious Diseases (@bwh_id) have found that the #SARS-CoV-2 mRNA-1273 vaccine showed 94.1% efficacy at preventing #Covid-19 illness.
Findings published in @NEJM:
https://t.co/8EK1POa56e
Adam Yala (@YalaTweets) in the lab of Dr. Regina Barzilay (@BarzilayRegina) at @MITEECS-@MIT has introduced a new mammography-based model for #BreastCancer risk, Mirai, to capture the unique properties of risk modeling.
https://t.co/U4dARBQWpq
On 2/23 MassBio will be joined by the @DeptofDefense for an informational session on funding and partnering opportunities. Tune in to learn about research programs of interest to the DoD and #Congress. Register - https://t.co/VT9lV8A4Eb
We are also looking for a postdoc to work on vascularized brain organoids in collaboration with Paola Arlotta @Harvard , Ed Boyden @MIT & our lab. This is an exciting project at the interface between #stemcells, #bioprinting, and brain function. Please RT!
Our startup idea was chosen among the four finalists to participate in the 2017 Cycle of the @MassBio@Mass_CONNECT Mentorship Program. We received valuable mentorship by expert entrepreneurs like, among others, Anjali Kumar and Craig Sorensen https://t.co/C1Liy7NqVJ
In partnership with @MassBio we would like to invite you to our February 11th webinar! This interactive discussion will feature a live Q&A session and include insights from experts in bioanalytical testing and gene therapy studies. Register: https://t.co/hMlzBQeZAS
Join our friends @JNJInnovation JLABS next week on 2/9 as they discuss the potential promise, challenges and use cases of the next generation of #digitalhealth monitoring and connection: https://t.co/moLpHR8X8Z
Congratulations to @BUMedicine's Dr. Michael Alosco on being awarded a grant from the National Institute of Neurological Disorders and Stroke (@NINDSfunding) to study the effectiveness of a second generation tau PET tracer in detecting #CTE. 🧠📷
https://t.co/EHD7jJkkAF
“Our great success has been built on a strong commitment to innovation through a combination of investments in both internal and external innovation.” -@mpreminger
Register for @MassBio's #PartneringWeek to learn about our mission & partnering approach: https://t.co/N3YXOeTXw5